Edition:
United Kingdom

India's Glaxosmithkline Consumer Healthcare Approves Amalgamation With Hindustan Unilever


Monday, 3 Dec 2018 

Dec 3 (Reuters) - Glaxosmithkline Consumer Healthcare Ltd ::SAYS APPROVED A SCHEME OF AMALGAMATION BETWEEN COMPANY AND HINDUSTAN UNILEVER LIMITED.SHARE EXCHANGE RATIO FOR AMALGAMATION TO BE 4.39 EQUITY SHARES OF HUL FOR EVERY SHARE OF CO.SCHEME IS SUBJECT TO NECESSARY STATUTORY AND REGULATORY APPROVALS.